cropped-DSC_0322.jpg
PhD student

Education

Since October 2017 – PhD Student in Public Health (ISPED) –  Surrogate end points of overall survival for metastatic cancer patients treated by immune-checkpoint inhibitors (Director: Virginie Rondeau & Carine Bellera)

2007-2009 – Master degree in Applied Statistics and Modelization, Montpellier University of Sciences

2006-2007 – GCE “A” levels in Biology, Montpellier University of Sciences.

Current job

Since June 2013 – Health Economics and Outcomes Research Manager – Bristol-Myers Squibb, Rueil Malmaison, France.

Publications

–    Rotily M., Abergel A., Branchoux S., Akremi R., de Léotoing L., Vainchtock A., Gaudin A.-F. Disparités regionales des hospitalisations pour complication de l’hépatite chronique C en 2012. Santé Publique. 2017; 29(2): 215-227.

–   Abergel A., Rotily M., Branchoux S., Akremi R., de Léotoing L., Vainchtock A., Gaudin A.-F. Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study). Clinics and Research in Hepatology and Gastroenterology. 2016; 40(3): 340–348.

– Wolkenstein P., Misery L., Amici J.-M., Maghia R., Branchoux S., Cazeau C., Voisard J.-J. Taïeb C. Smoking and dietary factors associated with moderate-to-severe acne in French adolescents and young adults: results of a survey using a representative sample. Dermatology. 2015; 230(1): 34-39.

– Benigni J.P., Branchoux S., Bacle I., Taieb C. Difficulty associated with donning medical compression stockings: results from a survey comparing two different compression stockings. Women’s Health. 2013; 9(3): 291–300.

– Pol S., Chevalier J., Branchoux S., Perry R., Milligan G., Gaudin A.-F. Health related quality of life and utility values in chronic hepatitis C patients: A cross-sectional study in France, the UK and Germany. Journal of Hepatology. 2015; 62: S263–S864

– Rotily M., Abergel A., Branchoux S., de Léotoing L., Vainchtock A., Akremi R., Gaudin A.-F. Burden of hospitalizations related to chronic hepatitis C in France: evolution between 2009 and 2012. Value in Health. 2014; 17(7): A364.

– Abergel A., Rotily M., Gaudin A-F., De Léotoing L., Vainchtock A., Akremi R., Branchoux S. Mean annual cost of patients hospitalized for chronic hepatitis C in France: The HEPC-LONE study. Value in Health. 2014; 17(7): A364.

– Fagnani F., Kusnik-Joinville O., De Zélicourt M., Lévy-Bachelot L., Branchoux S., Murat C., Bertrand M., Kahane P. Use of drug reimbursement as markers of disease for epidemiological and direct cost analysis: the case of epilepsy in France. Value in Health. 2011; 14(7); A321.

– Rajzbaum G., Lespessailles E., Gasquet I., Branchoux S., Cotte F.-E. EQ-5D visual analogue scale (VAS) and utility index values in French women with a diagnosis of post- menopausal osteoporosis. Value in Health. 2009; 12(7): A449.

logo_ISPED logo_SFR-santepublique-societe logo_CHU-Bordeaux logo_Institut-Bergonie logo_INRIA logo_ANRS logo_ARS logo_Charles-Perrens logo_IFSTTAR logo_HONcode